miR-584-5p Inhibits Osteosarcoma Progression by Targeting Connective Tissue Growth Factor

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNA-584-5p (miR-584-5p) is implicated in various cancers.
• Its specific function and targets in osteosarcoma remain largely unelucidated.
• The Hippo pathway's role in osteosarcoma requires further investigation.

Purpose of the Study:

• To investigate the role and molecular mechanisms of miR-584-5p in osteosarcoma.
• To identify downstream targets of miR-584-5p in osteosarcoma cells.
• To explore the interaction between miR-584-5p, CTGF, and the Hippo pathway in osteosarcoma.

Main Methods:

• Quantitative real-time PCR (RT-qPCR) for gene expression analysis.
• Cell Counting Kit-8 (CCK-8), EdU, and colony formation assays for proliferation assessment.
• Wound-healing and Transwell assays for migration and invasion evaluation.
• Flow cytometry for apoptosis detection.
• Western blot for protein expression analysis.

Main Results:

• Overexpression of miR-584-5p significantly repressed osteosarcoma cell proliferation, migration, and invasion.
• miR-584-5p directly targeted and negatively regulated connective tissue growth factor (CTGF).
• miR-584-5p inhibited osteosarcoma cell metastasis by modulating CTGF levels and inactivated the Hippo pathway via CTGF.

Conclusions:

• miR-584-5p functions as a tumor suppressor in osteosarcoma by targeting CTGF.
• miR-584-5p inhibits osteosarcoma cell proliferation, migration, and invasion while promoting apoptosis.
• miR-584-5p represents a potential diagnostic and predictive biomarker for osteosarcoma.